| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 07/17/2002 | EP1222260A1 Preparation of cellular components that are substantially free of chromosomal dna |
| 07/17/2002 | EP1222259A1 ALTERING GENE EXPRESSION WITH ssDNA PRODUCED IN VIVO |
| 07/17/2002 | EP1222253A1 Retinoid receptor interacting polynucleotides, polypeptides, and antibodies |
| 07/17/2002 | EP1222252A1 New lymphocytes, a process for preparing the same and their use in therapeutics |
| 07/17/2002 | EP1222251A1 Ex vivo generation of functional osteoclasts from bone marrow in a three-dimensional bioreactor |
| 07/17/2002 | EP1222226A1 Highly-neutralized ethylene copolymers and their use in golf balls |
| 07/17/2002 | EP1222212A1 Il13 mutants |
| 07/17/2002 | EP1222209A2 Modulation of t cell differentiation for the treatment of t helper cell mediated diseases |
| 07/17/2002 | EP1222208A1 Polypeptide derivatives of parathyroid hormone (pth) |
| 07/17/2002 | EP1222206A1 Pablo, a polypeptide that interacts with bcl-xl, and uses related thereto |
| 07/17/2002 | EP1222205A1 POLYNUCLEOTIDES ENCODING HUMAN AND MURINE ADHESION PROTEINS (BIgR) |
| 07/17/2002 | EP1222199A1 N-formyl peptide receptor complex with a g-protein kinase signal pathway modification agent |
| 07/17/2002 | EP1221969A2 Activation of antigen-specific t cells by virus/antigen-treated dendritic cells |
| 07/17/2002 | EP1221956A2 Autologous marrow stem cell (msc) transplantation for myocardial regeneration |
| 07/17/2002 | EP1221955A2 Immunostimulatory nucleic acids |
| 07/17/2002 | EP1221853A1 Oligodendrocyte cell cultures and methods for their preparation and use |
| 07/17/2002 | EP0954328A4 Laminin-5 and the formation of basement membrane structure |
| 07/17/2002 | EP0895538B1 Mutated ras peptides for generation of cd8+ cytotoxic t lymphocytes |
| 07/17/2002 | EP0868505A4 In vitro chondrogenic induction of human mesenchymal stem cells |
| 07/17/2002 | EP0830374B1 Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases |
| 07/17/2002 | EP0815450B1 Compounds and methods for the dectection of t. cruzi infection |
| 07/17/2002 | EP0804219B1 Inhibin compositions and methods of use thereof |
| 07/17/2002 | EP0734446B1 Controlled expression of transgenic constructs in plant plastids |
| 07/17/2002 | EP0614485B1 Methods for selectively expanding cd34 positive cells |
| 07/17/2002 | CN1359424A Pesticidal fusions |
| 07/17/2002 | CN1359423A Herbicide resistant plants |
| 07/17/2002 | CN1359422A Herbicide resistant plants |
| 07/17/2002 | CN1359388A Method for enhanced protein stabilization and production of cell liell lines useful for production of such stabilized proteins |
| 07/17/2002 | CN1087779C Macroencapsulated secretory cells |
| 07/17/2002 | CN1087778C Hybridizing tumour cell non-serum culture medium |
| 07/17/2002 | CN1087777C Human embryonic Iung fibroblast diploid cell strain suitable for production of virus and process for production of varicella zoster virus using same |
| 07/16/2002 | US6420628 Seed shattering |
| 07/16/2002 | US6420545 Nucleotide sequences coding polypeptide for use in the treatment of preferential viral diseases |
| 07/16/2002 | US6420542 Tie ligands |
| 07/16/2002 | US6420534 Alzheimer's disease secretase, APP substrates therefor, and uses thereof |
| 07/16/2002 | US6420532 Binding to human y2 receptors and expression |
| 07/16/2002 | US6420531 Polypeptides prepared by expressing in a host cell a dna code with amino acid sequence |
| 07/16/2002 | US6420530 Polymaleic acid polymer or copolymer with acrylic acid, maleic anhydride, ethyl acrylate or vinyl acetate |
| 07/16/2002 | US6420525 Human transcription factor ZGCL-1 |
| 07/16/2002 | US6420337 Protein isolated from egg whites and yolks of hyperimmunized animals; amino acid sequence seq id no:1 and 6; upregulation of tumor necrosis factor and interleukins-6 and -1beta; downregulation of transforming growth factor-beta |
| 07/16/2002 | US6420336 Purified antiviral protein, peptide or conjugate encoded by amino acid sequence 90% homologous to seq id no: 2; prophy-lactic or therapeutic inhibition of growth of a virus, such as a retrovirus; human immunodeficiency virus, hiv-1 or hiv-2 |
| 07/16/2002 | US6420174 Method of producing organogenetic tissue from a plant of the genus Mentha |
| 07/16/2002 | US6420173 Method for mass production and storage of seedlings of Eleutherococcus senticosus (Siberian ginseng) through cell culturing |
| 07/16/2002 | US6420172 Method for inducing tumor immunity |
| 07/16/2002 | US6420171 Composite material for use in the isolation of aggregations of cells associate with preferential blood disorders |
| 07/16/2002 | US6420170 Recombinant adenoviruses containing an inducible promoter controlling a gene of viral origin |
| 07/16/2002 | US6420159 1-deoxy-D-xylulose-5-phosphate reductoisomerases, and methods of use |
| 07/16/2002 | US6420157 Expression vector coding enzymatic polypeptide for use in the treatment of inflammation and sexual disorders; for use in laundry detergents |
| 07/16/2002 | US6420155 Polypeptide for use in the treatment of cancer and atherosclerosis |
| 07/16/2002 | US6420150 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof |
| 07/16/2002 | US6420140 Production of multimeric protein by cell fusion method |
| 07/16/2002 | US6420135 Streptococcus pneumoniae polynucleotides and sequences |
| 07/16/2002 | US6420124 KVLQT1—a long qt syndrome gene |
| 07/16/2002 | US6420120 Use of a polypeptide as cell receptor for adenoviruses |
| 07/16/2002 | US6420116 Protein for use in the human therapeutics and diagnosis |
| 07/16/2002 | US6420110 Methods and reagents for isolating biologically active peptides |
| 07/16/2002 | US6419929 Genetic engineering |
| 07/16/2002 | US6419928 Monoclonal antibodies to transforming growth factor-beta and methods of use |
| 07/16/2002 | US6419927 Method for reducing adverse effects of a human 70kDa mediator which results from endotoxin stimulation of macrophages |
| 07/16/2002 | US6419925 Toxoplasma gondii antigens, the preparation thereof and the use thereof |
| 07/16/2002 | US6419924 Prevent membrane formation; antiproliferative agents; antitumor agents |
| 07/16/2002 | US6419920 Insoluble collagen matrix |
| 07/16/2002 | US6419918 Receptors of chemotactic peptide; leukemia therapy |
| 07/16/2002 | CA2236158C Method for treating retinal ganglion cell injury using glial cell line-derived neurotrophic factor (gdnf) protein product |
| 07/16/2002 | CA2193094C The cytoplasmic inhibition of gene expression |
| 07/16/2002 | CA2095926C Anti-human milk fat globule humanised antibodies |
| 07/16/2002 | CA2090009C Methods for inhibiting rejection of transplanted tissue |
| 07/16/2002 | CA2024063C Antibodies directed against nerve growth factor-like peptides |
| 07/12/2002 | WO2003006635A1 Support for cell/tissue culture and culture mehtod |
| 07/12/2002 | CA2453539A1 Cell or tissue-culturing carrier, and culturing method |
| 07/11/2002 | WO2002054073A2 Latent human tuberculosis model, diagnostic antigens, and methods of use |
| 07/11/2002 | WO2002054065A2 Reversible mhc multimer staining for functional purification of antigen-specific t cells |
| 07/11/2002 | WO2002054064A2 Method for screening for progesterone receptor isoform-specific ligands |
| 07/11/2002 | WO2002054044A2 Focused acoustic ejection cell sorting system and method |
| 07/11/2002 | WO2002053775A2 Identification of genetic determinants of polymorphic cyp3a5 expression |
| 07/11/2002 | WO2002053761A2 Recombinant protective protein from $i(streptococcus pneumoniae) |
| 07/11/2002 | WO2002053757A1 Hiv-like particles and the use thereof |
| 07/11/2002 | WO2002053743A2 Mammalian tribbles signaling pathways and methods and reagents related thereto |
| 07/11/2002 | WO2002053742A2 Proteins and nucleic acids encoding same |
| 07/11/2002 | WO2002053740A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 07/11/2002 | WO2002053733A2 Regulation of human b7-h2 protein |
| 07/11/2002 | WO2002053728A2 Gene disruption methodologies for drug target discovery |
| 07/11/2002 | WO2002053717A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 07/11/2002 | WO2002053711A2 Use of transcription factor yb-1 in adenoviral systems |
| 07/11/2002 | WO2002053710A1 Mammalian cancer cell and transgenic mammal carrying human protooncogene and kit for diagnosing cancer using said protooncogene |
| 07/11/2002 | WO2002053708A1 Method for production of low-cost seeds of hybrid wheat |
| 07/11/2002 | WO2002053703A2 Aav2 vectors and methods |
| 07/11/2002 | WO2002053596A2 Antibodies to insulin-like growth factor i receptor |
| 07/11/2002 | WO2002053581A2 Spliceosome mediated rna trans-splicing |
| 07/11/2002 | WO2002053201A1 Use of a biological material containing three-dimensional scaffolds of hyaluronic acid derivatives for the preparation of implants in arthroscopy and kit for instruments for implanting said biological material by arthroscopy |
| 07/11/2002 | WO2002053193A2 Tissue engineering of three-dimensional vascularized using microfabricated polymer assembly technology |
| 07/11/2002 | WO2002053176A2 An autologous anti-cancer vaccine |
| 07/11/2002 | WO2002052936A1 Preserving agents for freeze-dried cells |
| 07/11/2002 | WO2002034923A8 Monocotyledon plant cells and plants which synthesise modified starch |
| 07/11/2002 | WO2002032288A3 Cd38 modulated chemotaxis |
| 07/11/2002 | WO2002022787A3 Differential treatment of selected parts of a single cell with different fluid components |
| 07/11/2002 | WO2002014511A3 Regulation of human p2y1-like g protein-coupled receptor |
| 07/11/2002 | WO2002014479B1 Isolated mammalian neural stem cells, methods of making such cells, and methods of using such cells |
| 07/11/2002 | WO2002010199A3 C3b/c4b complement receptor-like molecules and uses thereof |
| 07/11/2002 | WO2002008456A8 Method for identifying metastatic tumor cells |